117 related articles for article (PubMed ID: 20140858)
1. [Generation of factor VIII gene knockout mouse by tetraploid embryo complementation technology].
Kuang Y; Wang J; Lu X; Lu S; Zhang L; Shen C; Fei J; Wang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):1-6. PubMed ID: 20140858
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice.
Bolliger D; Szlam F; Suzuki N; Matsushita T; Tanaka KA
Thromb Haemost; 2010 Jun; 103(6):1233-8. PubMed ID: 20352163
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
4. Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.
Chao H; Mansfield SG; Bartel RC; Hiriyanna S; Mitchell LG; Garcia-Blanco MA; Walsh CE
Nat Med; 2003 Aug; 9(8):1015-9. PubMed ID: 12847523
[TBL] [Abstract][Full Text] [Related]
5. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
Liu L; Mah C; Fletcher BS
Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
[TBL] [Abstract][Full Text] [Related]
6. Phenotype correction of hemophilia A mice with adeno-associated virus vectors carrying the B domain-deleted canine factor VIII gene.
Ishiwata A; Mimuro J; Kashiwakura Y; Niimura M; Takano K; Ohmori T; Madoiwa S; Mizukami H; Okada T; Naka H; Yoshioka A; Ozawa K; Sakata Y
Thromb Res; 2006; 118(5):627-35. PubMed ID: 16371232
[TBL] [Abstract][Full Text] [Related]
7. [Molecular genetics of hemophilia A].
De Brasi CD; Slavutsky IR; Larripa IB
Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
[TBL] [Abstract][Full Text] [Related]
8. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.
Bi L; Lawler AM; Antonarakis SE; High KA; Gearhart JD; Kazazian HH
Nat Genet; 1995 May; 10(1):119-21. PubMed ID: 7647782
[TBL] [Abstract][Full Text] [Related]
10. Role of the intrinsic coagulation pathway in atherogenesis assessed in hemophilic apolipoprotein E knockout mice.
Khallou-Laschet J; Caligiuri G; Tupin E; Gaston AT; Poirier B; Groyer E; Urbain D; Maisnier-Patin S; Sarkar R; Kaveri SV; Lacroix-Desmazes S; Nicoletti A
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):e123-6. PubMed ID: 15920033
[TBL] [Abstract][Full Text] [Related]
11. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
[TBL] [Abstract][Full Text] [Related]
13. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
[TBL] [Abstract][Full Text] [Related]
14. Liver-restricted expression of the canine factor VIII gene facilitates prevention of inhibitor formation in factor VIII-deficient mice.
Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Takano K; Ohmori T; Madoiwa S; Ozawa K; Sakata Y
J Gene Med; 2009 Nov; 11(11):1020-9. PubMed ID: 19757487
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII can be synthesized in hemophilia A mice liver by bone marrow progenitor cell-derived hepatocytes and sinusoidal endothelial cells.
Yadav N; Kanjirakkuzhiyil S; Ramakrishnan M; Das TK; Mukhopadhyay A
Stem Cells Dev; 2012 Jan; 21(1):110-20. PubMed ID: 21480781
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions.
Sugita C; Yamashita A; Moriguchi-Goto S; Furukoji E; Takahashi M; Harada A; Soeda T; Kitazawa T; Hattori K; Tamura S; Asada Y
Thromb Res; 2009 Nov; 124(5):601-7. PubMed ID: 19660789
[TBL] [Abstract][Full Text] [Related]
17. Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.
Turecek PL; Gritsch H; Richter G; Auer W; Pichler L; Schwarz HP
Thromb Haemost; 1997 Mar; 77(3):591-9. PubMed ID: 9066015
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
Wang W; Merchlinsky M; Inman J; Golding B
Thromb Res; 2005; 116(4):335-44. PubMed ID: 16038719
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between genotypes and clinical phenotypes in patients from 7 hemophilia A families].
Liang WL; Wei HY; Liao N; Zhou JL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):903-7. PubMed ID: 26412167
[TBL] [Abstract][Full Text] [Related]
20. [Molecular analysis of a patient with hemophilia A caused by FVIII His99Arg mutation].
Qin HH; Wang XF; Ding QL; Lu YL; Dai J; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):587-91. PubMed ID: 22338150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
